Search bioRxiv⌕ Search

Biology subjects

Nag, N.

Publications and source records attributed to Nag, N..

2 recordsLinked to original sources

Heterotypic FG-Nup98-tau condensates form nested assemblies through stoichiometry-dependent phase transitions

The dysfunction of nucleocytoplasmic transport (NCT) and tau aggregation are emerging as interconnected hallmarks of neurodegenerative tauopathies. However, the molecular basis by which components of the nuclear pore complex and tau interact remains unclear. Here, we combine experimental and computational approaches to elucidate the mechanism of heterotypic phase separation between the FG-repeat domain of nucleoporin Nup98 (FG-Nup98) and tau. In vitro assays revealed that FG-Nup98 and tau undergo coacervation, forming dynamic condensates whose morphology and dynamics depend on stoichiometry, macromolecular crowding, and ionic strength. FRAP indicated reduced tau mobility within FG-Nup98-rich condensates, supporting a scaffold-client model. Complementary computational analyses revealed hierarchical binding energetics: FG-Nup98 self-association is strongest, followed by FG-Nup98-tau and tau-tau interactions. While FG-Nup98 forms stable homotypic networks, tau-tau contacts are transient but energetically favorable, which suggests that elevated tau concentrations may trigger a transition from droplets to tau aggregates. Together, these results establish that multivalent FG-Nup98-tau interactions drive condensate formation that could potentially perturb the permeability barrier of the nuclear pore. This study elucidates the coordinated behaviors of FG-Nup98-tau condensates and provides a framework for understanding NCT defects in tauopathies.

biochemistry↗

Metallo-protease Peptidase M84 from Bacillus altitudinis induces ROS dependent apoptosis in ovarian cancer cells by targeting PAR-1

In pursuit of isolating novel anticancer proteases from environmental microbial isolates, we have purified and identified an extracellular metallo-protease from Bacillus altitudinis named Peptidase M84. This protease selectively triggered apoptosis in human ovarian adenocarcinoma cells (PA-1, SKOV3) and mouse ovarian carcinoma cells (ID8), in addition to exhibiting no significant effect on normal human epithelial ovarian cell (IOSE) and mouse peritoneal macrophage (PEM[FE]) cell viabilities. Protease activated receptor-1 (PAR-1); a GPCR which is reported to be overexpressed in ovarian cancer cells was identified as a novel target of Peptidase M84. We observed that Peptidase M84 induced PAR-1 overexpression along with activating its downstream signalling effectors NF{kappa}B and MAPK to promote excessive reactive oxygen species (ROS) generation in ovarian cancer cells. This disrupted mitochondrial membrane potential, allowed cytosolic release of mitochondrial cytochrome c, increased the Bax (pro-apoptotic) to Bcl-2 (anti-apoptotic) ratio and promoted DNA damage to evoke apoptotic death of the ovarian cancer cells. Peptidase M84 also reduced nuclear ki-67 expression in these malignant cells to render an anti-proliferative role. In in vivo set-up, weekly intraperitoneal administration of Peptidase M84 (12 {micro}g/kg body-weight) in the ID8 mice model significantly diminished ascitic fluid accumulation through induction of oxidative stress, increasing murine survival rates by 60%. Collectively, our in vitro and in vivo findings suggested that Peptidase M84 triggered PAR-1 mediated oxidative stress to act as an apoptosis inducer in ovarian cancer cells. This established Peptidase M84 as a promising drug candidate for receptor mediated targeted-therapy of ovarian cancer. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=158 HEIGHT=200 SRC="FIGDIR/small/556500v2_ufig1.gif" ALT="Figure 1"> View larger version (51K): org.highwire.dtl.DTLVardef@6b0a19org.highwire.dtl.DTLVardef@1640510org.highwire.dtl.DTLVardef@1888b49org.highwire.dtl.DTLVardef@1708114_HPS_FORMAT_FIGEXP M_FIG C_FIG

cancer biology↗